Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 4 min ago

LabCorp Announces Appointment of Chief Financial Officer

Tue, 03/25/2014 - 15:13
Glenn A. Eisenberg Appointed as Executive Vice President and Chief Financial Officer Effective June 16, 2014 BURLINGTON, N.C.--(Healthcare Sales & Marketing Network)--Laboratory Corporation of America® Holdings (LabCorp®) (LH) today announced th...
Diagnostics, Personnel
Laboratory Corporation of America, LabCorp

Calithera Biosciences Appoints William D. Waddill Chief Financial Officer

Tue, 03/25/2014 - 15:11
SOUTH SAN FRANCISCO, Calif., March 25, 2014 -- (Healthcare Sales & Marketing Network) -- Calithera Biosciences, a clinical-stage biotechnology company focused on the development of novel cancer therapeutics, today announced the appointment of William D. W...
Biopharmaceuticals, Oncology, Personnel
Calithera Biosciences, glutaminase

Integra LifeSciences Launches Integra(R) Wound Matrix (Thin)

Tue, 03/25/2014 - 15:09
Expands Skin and Wound Product Line PLAINSBORO, N.J., March 25, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced the expansion of its skin and wound product line with the introduction of ...
Devices, Wound Care, Product Launch
Integra LifeSciences, Wound Matrix, skin graft

Tocagen Names Jamey Skillings, M.D., Chief Medical Officer

Tue, 03/25/2014 - 15:07
Pharmaceutical Executive Brings Additional Expertise in Oncology Drug Development and Commercialization Oversaw Approvals of Numerous Oncology Products, including Avastin®, Xalkori® and Erbitux® SAN DIEGO, March 25, 2014 -- (Healthcare Sa...
Biopharmaceuticals, Oncology, Personnel
Tocagen, immunotherapy

AcelRx Pharmaceuticals Appoints Timothy E. Morris as Chief Financial Officer

Tue, 03/25/2014 - 15:04
REDWOOD CITY, Calif., March 25, 2014 -- (Healthcare Sales & Marketing Network) -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute a...
Biopharmaceuticals, Personnel
AcelRx Pharmaceuticals, Zalviso

BrainStorm and Massachusetts General Hospital Sign Definitive Agreement for ALS Clinical Trial

Tue, 03/25/2014 - 12:28
NEW YORK, NY and PETACH TIKVAH, ISRAEL--(Healthcare Sales & Marketing Network) - BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it has signed a definitive...
Regenerative Medicine, Neurology
BrainStorm Cell Therapeutics, NurOwn , amyotrophic lateral sclerosis, stem cell

Exelixis Receives Approval for COMETRIQ(R) (Cabozantinib) in the European Union for Treatment of Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma

Tue, 03/25/2014 - 12:19
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Exelixis, Inc. (EXEL) today announced that the European Commission has approved COMETRIQ® (cabozantinib) for the treatment of adult patients with progressive, unresectable locally adv...
Biopharmaceuticals, Oncology, Regulatory
Exelixis, COMETRIQ, cabozantinib, medullary thyroid carcinoma

FDA Grants Diazyme 510(k) Clearance to Market Its Vitamin D Assay for Clinical Chemistry Analyzers

Mon, 03/24/2014 - 15:17
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Diazyme Laboratories today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market its Vitamin D assay for Clinical Chemistry Analyzers. In line with the rapi...
Diagnostics, FDA
Diazyme, General Atomics, Vitamin D assay

BEAT BioTherapeutics Appoints Dr. Sam L. Teichman as Chief Medical Officer

Mon, 03/24/2014 - 15:12
SEATTLE--(Healthcare Sales & Marketing Network)--BEAT BioTherapeutics Corp. (BEATBio) announced today the appointment of Sam L. Teichman, MD, FACC, FESC, FACP, as Chief Medical Officer (CMO) and Director. BEATBio is developing BB-R12, a novel biological th...
Biopharmaceuticals, Cardiology, Personnel
BEAT BioTherapeutics, BEATBio, BB-R12, heart failure

Health Canada Approves Biogen Idec's Long-Acting ALPROLIX(TM) Therapy for Hemophilia B

Mon, 03/24/2014 - 13:25
The Approval of ALPROLIX is First Significant Advance in Hemophilia B Treatment in More Than 17 Years CAMBRIDGE, MA, March 24, 2014 (Healthcare Sales & Marketing Network) - Biogen Idec (BIIB) has announced that Health Canada approved ALPROLIX™ [Coagulat...
Biopharmaceuticals, Regulatory
Biogen Idec, ALPROLIX, hemophilia B

St. Jude Medical Announces Global Launch of Optisure Defibrillation Lead

Mon, 03/24/2014 - 13:15
The Optisure lead expands on the St. Jude Medical high-voltage product portfolio, providing an additional system enhancement for addressing lead complications and improving system reliability ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. ...
Devices, Cardiology, Product Launch
St. Jude Medical, Optisure Defibrillation Lead, ICD , CRT-D

St. Jude Medical Announces FDA Approvals of New Pacemakers

Mon, 03/24/2014 - 13:04
First pacemaker with quadripolar technology now available in the U.S. ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global medical device company, today announced approval from the U.S. Food and Drug Administra...
Devices, Cardiology, FDA
St. Jude Medical, Allure Quadra, CRT-P, Assurity, Endurity, pacemaker

AMRI to Acquire Cedarburg Pharmaceuticals, Inc.

Mon, 03/24/2014 - 12:56
ALBANY, N.Y., March 24, 2014 -- (Healthcare Sales & Marketing Network) -- AMRI (AMRI) today announced that it has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals, Inc. for $38.2 million in cash. The transac...
Biopharmaceuticals, Mergers & Acquisitions
AMRI, Albany Molecular Research, Cedarburg Pharmaceuticals

Aerotel Receives CE Mark Approval for Its New ECG Devices, HeartView P12/8i and HeartView 12L

Mon, 03/24/2014 - 12:49
New devices feature advanced technology providing capability for high-resolution ECG recordings with immediate transmission capability via the Mobile network. HOLON, Israel, March 24, 2014 -- (Healthcare Sales & Marketing Network) --develop high-qualit...
Devices, Cardiology, Monitoring, Regulatory
Aerotel Medical Systems, HeartView P12/8i, HeartView 12L, Heartline ECG

Taiho's Lonsurf(R) (trifluridine and tipiracil hydrochloride) Tablets Approved In Japan for Treatment of Advanced Metastatic Colorectal Cancer

Mon, 03/24/2014 - 12:41
TOKYO, March 24, 2014 -- (Healthcare Sales & Marketing Network) -- Taiho Pharmaceutical Co., Ltd. (Tokyo, President: Masayuki Kobayashi) announced on March 24 that it has obtained approval in Japan from the Ministry of Health, Labour and Welfare to manufa...
Biopharmaceuticals, Oncology, Regulatory
Taiho Pharmaceutical, Lonsurf, trifluridine, tipiracil, colorectal cancer

Otsuka Pharmaceutical's Samsca(R) Approved in Japan as the World's First Drug Therapy for ADPKD, a Rare Kidney Disease

Mon, 03/24/2014 - 12:35
Samsca, discovered and developed by Otsuka Pharmaceutical Co., has been approved in Japan as the first drug treatment in the world to slow the progression of autosomal dominant polycystic kidney disease (ADPKD). With Samsca, long-term progression of the di...
Biopharmaceuticals, Regulatory
Otsuka Pharmaceutical, Samsca, tolvaptan, ADPKD, polycystic kidney disease

Exact Sciences Announces Appointment of Kevin Conroy as Chairman of the Board; David Thompson to Serve as Lead Independent Director

Fri, 03/21/2014 - 15:04
MADISON, Wis.--(Healthcare Sales & Marketing Network)--Exact Sciences Corp. (EXAS) today announced that its board of directors has appointed Kevin T. Conroy, the company’s president and chief executive, as chairman of the board. David A. Thompson, a direct...
Diagnostics, Oncology, Personnel
Exact Sciences, molecular diagnostics, colorectal cancer

Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT(R) (vintafolide) and Companion Imaging Agents FOLCEPRI(R) (etarfolatide) and NEOCEPRI(R) (Intravenous (IV) folic acid) in Patients with Platinum-Resistant Ovarian Cancer

Fri, 03/21/2014 - 15:01
WHITEHOUSE STATION, N.J. & WEST LAFAYETTE, Ind.--(Healthcare Sales & Marketing Network)--Merck (MRK), known as MSD outside the United States and Canada, and Endocyte, Inc. (ECYT), today announced that the Committee for Medicinal Products for Human Use (CHM...
Biopharmaceuticals, Oncology, Radiology, Regulatory
Merck, Endocyte, VYNFINIT, vintafolide, FOLCEPRI, etarfolatide, ovarian cancer

Genzyme’s Lemtrada(TM) Approved in Brazil for Treatment of Multiple Sclerosis

Fri, 03/21/2014 - 13:51
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that Brazil’s national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients ...
Biopharmaceuticals, Neurology, Regulatory
Genzyme, Sanofi, Lemtrada, alemtuzumab, multiple sclerosis

ZELTIQ(R) Aesthetics Launches CoolSmooth(TM) Applicator

Fri, 03/21/2014 - 13:45
Newest Applicator Adds Non-Pinchable Fat to List of Problems Areas Successfully Treated by CoolSculpting Procedure PLEASANTON, CA--(Healthcare Sales & Marketing Network) - ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on d...
Devices, Dermatology, Product Launch
ZELTIQ Aesthetics, CoolSmooth applicator, CoolSmooth, CoolSculpting

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong